Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1244
-
Total 13F shares, excl. options
-
91.3M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$80.2B
-
Value change
-
+$1.21B
-
Put/Call ratio
-
1.43
-
Number of buys
-
533
-
Number of sells
-
-502
-
Price
-
$878.29
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2023
1,391 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2023.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,244 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.3M shares
of 105M outstanding shares and own 86.96% of the company stock.
Largest 10 shareholders include FMR LLC (10.3M shares), VANGUARD GROUP INC (8.84M shares), BlackRock Inc. (8.63M shares), JPMORGAN CHASE & CO (7.23M shares), Capital World Investors (5.13M shares), STATE STREET CORP (4.9M shares), Capital International Investors (2.92M shares), Dodge & Cox (2.37M shares), GEODE CAPITAL MANAGEMENT, LLC (2.35M shares), and LOOMIS SAYLES & CO L P (1.22M shares).
This table shows the top 1244 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.